Emergen Research reports that the global blood pressure monitoring devices market is expected to reach USD 3.18 Billion by 2028 and register a steady CAGR over the forecast period. Among the major factors propelling the global blood pressure monitoring device market are rapid developments in healthcare technology, an increasing prevalence of cardiovascular diseases and hypertension, a growing geriatric population and associated health conditions, and an increasing prevalence of lifestyle diseases.
In healthcare settings, the reliability and accuracy of blood pressure monitoring systems are critical. The need for more accurate measuring devices has led leading medical device manufacturers to develop more advanced and accurate devices and systems.
Blood pressure monitoring devices market growth is expected to be further boosted by the miniaturization of medical devices, which has opened up huge opportunities for market players.
With the advent of digitalized blood pressure machines, mobile-based monitoring, and sensor-based devices, the demand for automated blood pressure monitoring devices is expected to grow during the forecast period. In addition to increasing government support, major manufacturing companies are also investing in the market.
The key players involved in the market are Koninklijke Philips N.V., General Electric Company, A&D Company, Ltd., Welch Allyn, SunTech Medical, Inc., American Diagnostic Corp., Withings, Briggs Healthcare, Spacelabs Healthcare, and Kaz Inc.
The report includes the following key findings:
As a result of the increasing number of private hospitals in developing countries and the rising adoption of technologically advanced medical devices, the global blood pressure monitoring devices market is expected to grow robustly during the forecast period.
In 2020, Europe accounted for the second largest revenue share in the global market. In this region, technological advancements and an increasing geriatric population are driving the growth of the market.
